Hideaki Yano, Ph.D.
Affiliations: | Pharmacology and Molecular Signaling | Columbia University, New York, NY |
Area:
G-protein coupled receptors and neurotransmitter transportersGoogle:
"Hideaki Yano"Mean distance: 18.76 (cluster 11)
Parents
Sign in to add mentor| Jonathan A. Javitch | grad student | 2012 | Columbia | |
| (Deconstructing G Protein-Coupled Receptor Dimer Pharmacology: Case Studies in Dopamine D1 and D2 Receptors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pavletić P, Semeano A, Yano H, et al. (2022) Highly Potent and Selective Dopamine D Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma. Journal of Medicinal Chemistry. 65: 12124-12139 |
| Adhikari P, Xie B, Semeano A, et al. (2021) Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. Biomolecules. 11 |
| Yano H, Adhikari P, Naing S, et al. (2020) Positive allosteric modulation of the 5-HT receptor by indole-based synthetic cannabinoids abused by humans. Acs Chemical Neuroscience |
| Abramyan AM, Yano H, Xu M, et al. (2020) The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor. Computational and Structural Biotechnology Journal. 18: 199-206 |
| Sanchez-Soto M, Verma RK, Willette BKA, et al. (2020) A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. Science Signaling. 13 |
| Lane JR, Abramyan AM, Adhikari P, et al. (2020) Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism. Elife. 9 |
| Köfalvi A, Moreno E, Cordomí A, et al. (2020) Control of glutamate release by complexes of adenosine and cannabinoid receptors. Bmc Biology. 18: 9 |
| Lane JR, Abramyan AM, Adhikari P, et al. (2020) Author response: Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism Elife |
| Adhikari P, Yano H, Bonifazi A, et al. (2020) Chirality of novel bitopic agonists determine unique pharmacology at the dopamine 2 and 3 receptors The Faseb Journal. 34: 1-1 |
| Yano H, Liu L, Naing S, et al. (2019) The Effects of Terminal Tagging on Homomeric Interactions of the Sigma 1 Receptor. Frontiers in Neuroscience. 13: 1356 |